Skip to content

Drug interactions

Bosentan + Metformin-pioglitazone

Severity: Minor

Bosentan and Metformin-pioglitazone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bosentan is a modest enzyme inducer and may lower pioglitazone exposure, potentially weakening glycemic control. Bosentan can also cause fluid retention, which may add to the edema risk of pioglitazone.

What this interaction means in plain words

Bosentan and Metformin-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Bosentan belongs to Miscellaneous; Metformin-pioglitazone belongs to Endocrine.

Evidence level: Low

Why it happens

Induction of hepatic CYP enzymes increases pioglitazone clearance; additive fluid retention is pharmacodynamic.

What to do

Monitor blood glucose and signs of fluid retention or heart failure, and adjust pioglitazone if control worsens.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bosentan and Metformin-pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bosentan with Metformin-pioglitazone?

MediHelp rates the interaction as minor. Bosentan and Metformin-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Bosentan is a modest enzyme inducer and may lower pioglitazone exposure, potentially weakening glycemic control. Bosentan can also cause fluid retention, which may add to the edema risk of pioglitazone.

How serious is the interaction between Bosentan and Metformin-pioglitazone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and signs of fluid retention or heart failure, and adjust pioglitazone if control worsens.

What other medicines interact with Metformin-pioglitazone?

MediHelp also lists interactions of Metformin-pioglitazone with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Metformin-pioglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in